| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChiefDERIV | Mar 5 | AAward | 1,157 | $0.00 | —? | 1,157derivatives |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChiefDERIV | Mar 5 | MOption exercise | 7,288 | $0.00 | —? | 3,062derivatives |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChiefDERIV | Mar 5 | MOption exercise | 6,825 | $0.00 | —? | 4,375derivatives |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Mar 5 | AAward | 2,061 | $0.00 | — | 5,789 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Mar 5 | S | 1,412 | $344.76 | $487K | 3,728 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Mar 5 | S | 4,701 | $343.85 | $1.6M | 5,140 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Mar 5 | S | 1,077 | $342.90 | $369K | 9,841 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Mar 5 | S | 1,043 | $341.84 | $357K | 10,918 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Mar 5 | S | 1,657 | $340.75 | $565K | 11,961 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Mar 5 | S | 400 | $339.68 | $136K | 13,618 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Mar 5 | S | 1,146 | $338.09 | $387K | 14,018 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Mar 5 | S | 1,777 | $336.78 | $598K | 15,164 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Mar 5 | S | 900 | $335.15 | $302K | 16,941 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Mar 5 | MOption exercise | 7,288 | $87.09 | $635K | 17,841 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Mar 5 | MOption exercise | 6,825 | $87.92 | $600K | 10,553 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Feb 28 | S | 175 | $341.55 | $60K | 3,728 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Feb 28 | S | 1,052 | $340.99 | $359K | 3,903 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Jan 24 | S | 103 | $335.24 | $35K | 4,955 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | Robert E. WaltermireChief | Jan 17 | S | 442 | $273.41 | $121K | 5,058 |